Articles with "therapeutic modifications" as a keyword



Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma

Sign Up to like & get
recommendations!
Published in 2023 at "Cancers"

DOI: 10.3390/cancers15051568

Abstract: Simple Summary We aimed to evaluate the impact of therapeutic modifications of atezolizumab (Atezo) plus bevacizumab (Bev) therapy (Atezo/Bev) in the case of intolerable adverse events on the prognosis of patients with unresectable hepatocellular carcinoma.… read more here.

Keywords: overall survival; atezo bev; discontinuation atezo; discontinuation ... See more keywords